Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 1:49 AM ET

Company Overview of Ontario Institute For Cancer Research

Company Overview

101 College St Suite 800

Toronto, ON M5g 1l7


Founded in 2001



Key Executives for Ontario Institute For Cancer Research

President and Scientific Director
Chief Operating Officer
Deputy Director and Chief Scientific Officer
Age: 62
Chief Commercial Officer
Corporate Secretary
Compensation as of Fiscal Year 2015.

Ontario Institute For Cancer Research Key Developments

The Ontario Institute for Cancer Research and Novera Therapeutics Collaborate with Janssen Biotech

The Ontario Institute for Cancer Research and Novera Therapeutics have collaborated with Johnson & Johnson's Janssen Biotech. The collaboration is aimed at accelerating the development of small molecule drugs for haematological cancers. By collaborating with University Health Network, Novera intends to discover and develop novel therapeutic compounds identified through Ontario Institute for Cancer Research's drug discovery programme. The firm will coordinate the partnership with Janssen under a license option and exclusive license agreement. The contract will see Novera receive an upfront payment and make it eligible to receive various pre-clinical, clinical, regulatory and commercialisation payments up to a total of around CAD 450 million. Janssen Biotech has been granted an exclusive option to license candidate drugs that have been identified through the collaboration, for all human uses globally. The firm will also manage responsibility for subsequent pre-clinical, clinical and commercial development upon exercising of its option. Under the collaboration, The Ontario Institute for Cancer Research will identify, fund and support oncology innovations in a bid to improve clinical practice.

Ontario Institute for Cancer Research Extends Collaboration with Janssen Inc. to Develop Clinical Trials for Prostate Cancer

The Ontario Institute for Cancer Research (OICR) is extending its collaborative research partnership with Janssen Inc. to develop more multi-centre clinical trials and other translational research projects that address important clinical questions in prostate cancer. The new funds will be made available to qualifying researchers at cancer centres across Canada who are addressing important clinical questions in prostate cancer. The funding will be dispersed to researchers through the Canadian Cancer Clinical Trials Network, which is based at OICR, through an open application process.

Similar Private Companies By Industry

Company Name Region
The Commercial Realty Group Ltd. Americas
Groupe Yves Gagnon Americas
Janda Countryside Shopping Centre Americas
Vega Resources, Ltd. Americas
Loblaw Properties West Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ontario Institute For Cancer Research, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at